Literature DB >> 11926184

Immunoglobulin (Ig)/BCL6 versus non-Ig/BCL6 gene fusion in diffuse large B-cell lymphoma corresponds to a high- versus low-level expression of BCL6 mRNA.

Chiyoko Ueda, Takashi Uchiyama, Hitoshi Ohno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11926184     DOI： 10.1182/blood-2001-11-0117

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

Review 1.  A Novel Non-Immunoglobulin (non-Ig)/BCL6 Translocation in Diffuse Large B-Cell Lymphoma Involving Chromosome 10q11.21 Loci and Review on Clinical Consequences of BCL6 Rearrangements.

Authors:  Marie Jarosova; Eva Kriegova; Petra Schneiderova; Regina Fillerova; Vit Prochazka; Michaela Mikesova; Patrik Flodr; Karel Indrak; Tomas Papajik
Journal:  Pathol Oncol Res       Date:  2015-08-30       Impact factor: 3.201

2.  Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma.

Authors:  J Iqbal; T C Greiner; K Patel; B J Dave; L Smith; J Ji; G Wright; W G Sanger; D L Pickering; S Jain; D E Horsman; Y Shen; K Fu; D D Weisenburger; C P Hans; E Campo; R D Gascoyne; A Rosenwald; E S Jaffe; J Delabie; L Rimsza; G Ott; H K Müller-Hermelink; J M Connors; J M Vose; T McKeithan; L M Staudt; W C Chan
Journal:  Leukemia       Date:  2007-07-12       Impact factor: 11.528

3.  Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP.

Authors:  Jesse Shustik; Guangming Han; Pedro Farinha; Nathalie A Johnson; Susana Ben Neriah; Joseph M Connors; Laurie H Sehn; Douglas E Horsman; Randy D Gascoyne; Christian Steidl
Journal:  Haematologica       Date:  2009-10-01       Impact factor: 9.941

4.  BCL6 breaks occur at different AID sequence motifs in Ig-BCL6 and non-Ig-BCL6 rearrangements.

Authors:  Zhengfei Lu; Albert G Tsai; Takashi Akasaka; Hitoshi Ohno; Yanwen Jiang; Ari M Melnick; Harvey A Greisman; Michael R Lieber
Journal:  Blood       Date:  2013-03-08       Impact factor: 22.113

5.  Prognostic Significance of in situ Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas.

Authors:  Alexandar Tzankov; Philip Went; Stephan Dirnhofer
Journal:  Biomark Insights       Date:  2007-11-11

6.  Generation and characteristics of a novel "double-hit" high grade B-cell lymphoma cell line DH-My6 with MYC/IGH and BCL6/IGH gene arrangements and potential molecular targeted therapies.

Authors:  Hiroaki Kikuchi; Tomonori Higuchi; Yumiko Hashida; Ayuko Taniguchi; Mikio Kamioka; Takahiro Taguchi; Akihito Yokoyama; Ichiro Murakami; Mikiya Fujieda; Masanori Daibata
Journal:  Oncotarget       Date:  2018-09-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.